Imfinzi (durvalumab) - AstraZeneca
SOMther (lutetium-177 DOTA satoreotide) - Ariceum Therap
Tecentriq (atezolizumab) - Roche
Zynyz (retifanlimab-dlwr) - Incyte
225Ac-satoreotide - Ariceum Therap
Bavencio (avelumab) - EMD Serono
Keytruda (pembrolizumab) - Merck (MSD)
http://clinicaltrials.gov/ct2/show/NCT06939036
 
Feb 6, 2026
 
Next